Crucell N.V.

Located in The Netherlands, Crucell's mission is the development of products to prevent and treat infectious diseases.

Crucell has more than 25 licensees using the company's unique PER.C6™ technology to develop their own products. Licensees include Merck and Company for an HIV vaccine; and in other therapeutic areas, GenVec, Aventis, Centocor/Johnson & Johnson, and Schering AG/Collateral. 
Back to Clients List